Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
17 Cards in this Set
- Front
- Back
31. Premature ovarian failure?
|
a. Any time menopause occurs w/o another etiology before age 40.
b. Before 35, chromosomal analysis is usually performed. |
|
32. Effect of chronic anovulation from Stein-Leventhal syndrome (PCOS)?
|
a. Leads to elevated oestrogen and androgen..
b. The excess androgen is converted peripherally to oestrogen by adipose. c. Further, the elevated androgens lead to a decrease in the production of sex hormone binding globulin (SHBG), resulting in even higher levels of free oestrogen and androgens. |
|
33. Effect of Stein-Leventhal syndrome (PCOS) on LH/FSH?
|
a. The hyperestrogenic state leads to an increased LH:FSH ratio, atypical follicular development, anovulation, and increased androgen production.
|
|
34. Tx of Stein-Leventhal syndrome (PCOS) pts who wish to become pregnant?
|
1. Clomiphene citrate
2. Corticosteroids 3. Metformin |
|
35. Tx of Stein-Leventhal syndrome (PCOS) who do not wish to become pregnant?
|
a. Either cyclic progestins or Depo-Provera to ↓ risk of endometrial hyperplasia and cancer 2º to unopposed ostrogen.
|
|
36. What is prolactin release inhibited and stimulated by?
|
a. Inhibited by dopamine
b. Stimulated by Thyrotropin-releasing hormone (TRH): so hypothyroid people w/excess TRH will have ↑ prolactin and 2º amenorrhea. |
|
37. Meds that ↑ prolactin levels?
|
a. Dopamine antagonists (Haldol, Reglan, Phenothiazines)
b. TCAs c. Estrogen d. MAOIs e. Opiates. |
|
38. Note: Empty Sella syndrome: in which the subarachnoid membrane herniates into the sella turcica, causing it to enlarge and flatten, is another cause of Hyperprolactinemia.
|
38. Note: Empty Sella syndrome: in which the subarachnoid membrane herniates into the sella turcica, causing it to enlarge and flatten, is another cause of Hyperprolactinemia.
|
|
39. Approach to 2º amenorrhea?
|
a. First get β-HCG to r/o pregnancy.
b. Check prolactin and TSH levels. (if both elevated, tx hypothyroidism) c. If prolactin is normal, do progesterone challenge |
|
40. Progesterone challenge?
|
10mg orally for 7-10 days progesterone to mimic progesterone withdrawal.
b. Performed to assess adequacy of endogenous oestrogen production and outflow tract. |
|
41. Withdrawal bleeding occurring after progesterone challenge indicates?
|
a. The presence of oestrogen and an adequate outflow tract.
b. In this case, amenorrhea is usually secondary to anovulation, which can be caused by a variety of endocrine disorders that alter the pituitary/gonadal feedback such as PCOS, tumours or ovary and adrenals, Cushing, thyroid disorders, and adult onset of adrenal hyperplasia. |
|
42. Absence of withdrawal bleeding occurring after progesterone challenge indicates?
|
a. Must then be evaluated w/oestrogen and progesterone administration.
b. If there is still no menstrual bleeding, an outflow tract disorder such as Asherman syndrome (intrauterine adhesions) or cervical stenosis is suspected. |
|
43. If there is bleeding after giving oestrogen/progesterone?
|
a. Suggests intact and functional uterus w/o adequate endogenous oestrogen stim.
b. Measure FSH and LH to differentiate b/t hypothalamic/pituitary disorder (low/normal FSH and LH) and c. Ovarian failure (High FSH/LH). |
|
44. Tx of macroadenomas?
|
a. Surgical resection.
b. Some pts w/macroadenomas and most w/microadenomas are tx w/bromocriptine. Dopamine agonist that often causes tumour regression and resumption of ovulation. |
|
45. Tx of pts who respond to progesterone challenge?
|
a. Should be withdrawn w/progesterone on a regular basis to prevent endometrial hyperplasia.
b. OCPs are useful in this case and may be beneficial in management of hirsutism. c. Contraindicated if pt is a smoker >35. In this case, progesterone alone is indicated due to ↑’d risk of CVA and venous thromboembolism w/oestrogen usage. |
|
46. Ovulation induction for pts w/hyperprolactinemia?
|
a. Bromocriptine.
|
|
47. Ovulation induction for pts who respond to progesterone challenge?
|
a. Clomiphene citrate, which acts as an antiestrogen to stimulate gonadotropin release.
|